Team at Shanxi Medical University develops melanin-based non-toxic nanocarrier for tumor treatment

The group of ZHANG Ruiping has developed water-soluble melanin-based nanoparticles (MNP) which have been loaded with the anti-cancer drug sorafenib and nuclide 64Cu, permitting tumor PET and PAI bimodal molecular imaging guided chemotherapy.

China Bio news release, August 25, 2015

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny